Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
9.56
+0.11 (1.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
Astria Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 80.9 | 175.53 | 20.53 | 86.51 | 24.93 | 9.9 | Upgrade
|
| Short-Term Investments | 263.38 | 71 | 205.91 | 39 | 20 | 26.35 | Upgrade
|
| Cash & Short-Term Investments | 344.28 | 246.53 | 226.44 | 125.51 | 44.93 | 36.24 | Upgrade
|
| Cash Growth | 82.35% | 8.87% | 80.42% | 179.34% | 23.97% | -3.53% | Upgrade
|
| Prepaid Expenses | 7.58 | 4.25 | 1.25 | 1.45 | 1.4 | 2.71 | Upgrade
|
| Restricted Cash | - | 0.16 | - | 0.12 | - | - | Upgrade
|
| Total Current Assets | 351.86 | 250.94 | 227.69 | 127.08 | 46.33 | 38.96 | Upgrade
|
| Property, Plant & Equipment | 5.39 | 0.36 | 0.95 | 0.39 | 0.97 | 2.35 | Upgrade
|
| Other Long-Term Assets | 4.39 | 3.36 | 2 | 0.05 | 0.17 | 0.47 | Upgrade
|
| Total Assets | 361.64 | 254.67 | 230.63 | 127.51 | 47.46 | 41.78 | Upgrade
|
| Accounts Payable | 1.28 | 1.51 | 0.79 | 1.56 | 1.54 | 1.2 | Upgrade
|
| Accrued Expenses | 13.07 | 9.71 | 7.69 | 3.28 | 4.2 | 2.61 | Upgrade
|
| Current Portion of Leases | 1.38 | 0.33 | 0.58 | 0.37 | 0.65 | 1.23 | Upgrade
|
| Total Current Liabilities | 15.72 | 11.55 | 9.06 | 5.2 | 6.39 | 5.03 | Upgrade
|
| Long-Term Leases | 4.26 | - | 0.36 | - | 0.4 | 1.03 | Upgrade
|
| Total Liabilities | 19.99 | 11.55 | 9.42 | 5.2 | 6.79 | 6.06 | Upgrade
|
| Common Stock | 0.06 | 0.04 | 0.03 | 0.01 | 0 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 895.11 | 728.29 | 632.51 | 481.71 | 301.56 | 259.31 | Upgrade
|
| Retained Earnings | -649.17 | -580.53 | -507.64 | -455.81 | -260.9 | -223.6 | Upgrade
|
| Comprehensive Income & Other | 0.33 | - | -0.08 | - | - | - | Upgrade
|
| Total Common Equity | 246.33 | 147.79 | 124.82 | 25.91 | 40.67 | 35.72 | Upgrade
|
| Shareholders' Equity | 341.65 | 243.12 | 221.22 | 122.31 | 40.67 | 35.72 | Upgrade
|
| Total Liabilities & Equity | 361.64 | 254.67 | 230.63 | 127.51 | 47.46 | 41.78 | Upgrade
|
| Total Debt | 5.64 | 0.33 | 0.94 | 0.37 | 1.05 | 2.25 | Upgrade
|
| Net Cash (Debt) | 338.65 | 246.2 | 225.5 | 125.14 | 43.88 | 33.99 | Upgrade
|
| Net Cash Growth | 79.83% | 9.18% | 80.19% | 185.17% | 29.10% | -9.53% | Upgrade
|
| Net Cash Per Share | 6.67 | 8.17 | 15.42 | 14.02 | 14.35 | 18.21 | Upgrade
|
| Filing Date Shares Outstanding | 56.43 | 54.9 | 27.99 | 13.02 | 3.9 | 2.98 | Upgrade
|
| Total Common Shares Outstanding | 56.43 | 41.03 | 27.5 | 13.02 | 3.35 | 2.07 | Upgrade
|
| Working Capital | 336.14 | 239.39 | 218.63 | 121.87 | 39.94 | 33.93 | Upgrade
|
| Book Value Per Share | 4.36 | 3.60 | 4.54 | 1.99 | 12.15 | 17.24 | Upgrade
|
| Tangible Book Value | 246.33 | 147.79 | 124.82 | 25.91 | 40.67 | 35.72 | Upgrade
|
| Tangible Book Value Per Share | 4.36 | 3.60 | 4.54 | 1.99 | 12.15 | 17.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.